Reference
Vivekanandarajah A, et al. Achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme: A case report. Clinical Medicine Insights: Oncology 5: 15-21, Feb 2011. Available from: URL: http://doi.org/10.4137/CMO.S6525 - USA
Rights and permissions
About this article
Cite this article
Bevacizumab/Irinotecan. Reactions Weekly 1572, 42 (2015). https://doi.org/10.1007/s40278-015-1067-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-1067-y